SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4) Reinsurance Group of America, Incorporated -------------------------------------------------------- (Name of Issuer) Common Stock, Par Value $.01 Per Share -------------------------------------------------------- (Title of Class of Securities) 759351109 -------------------------------------------------------- (CUSIP Number) Gwenn L. Carr MetLife, Inc. One Madison Avenue New York, New York 10010 (212)578-2211 -------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) January 30, 2002 -------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ]. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
SCHEDULE 13D CUSIP No. 759351109 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) MetLife, Inc. 13-4075851 - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS WC - ------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY 222,800* OWNED BY ---------------------------------------------------------- EACH 8 SHARED VOTING POWER REPORTING PERSON 28,915,939* WITH ---------------------------------------------------------- 9 SOLE DISPOSITIVE POWER 222,800* ---------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 28,915,939* - ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 29,138,739* - ------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] - ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 58.9%* - ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON HC - ------------------------------------------------------------------------------- * See Item 5 below. Unless otherwise indicated, all information relating to beneficial ownership of the Shares by the Reporting Persons is as of February 15, 2002. Page 2 of 26
SCHEDULE 13D CUSIP No. 759351109 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Metropolitan Life Insurance Company 13-5581829 - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable - ------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION New York - ------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY None* OWNED BY ---------------------------------------------------------- EACH 8 SHARED VOTING POWER REPORTING PERSON 28,915,939* WITH ---------------------------------------------------------- 9 SOLE DISPOSITIVE POWER None* ---------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 28,915,939* - ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 28,915,939* - ------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] - ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 58.5%* - ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IC - ------------------------------------------------------------------------------- * See Item 5 below. Unless otherwise indicated, all information relating to beneficial ownership of the Shares by the Reporting Persons is as of February 15, 2002. Page 3 of 26
SCHEDULE 13D CUSIP No. 759351109 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) GenAmerica Financial Corporation 43-1779470 - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable - ------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Missouri - ------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY None* OWNED BY ---------------------------------------------------------- EACH 8 SHARED VOTING POWER REPORTING PERSON 24,131,250* WITH ---------------------------------------------------------- 9 SOLE DISPOSITIVE POWER None* ---------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 24,131,250* - ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 24,131,250* - ------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] - ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 48.8%* - ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON HC, CO - ------------------------------------------------------------------------------- * See Item 5 below. Unless otherwise indicated, all information relating to beneficial ownership of the Shares by the Reporting Persons is as of February 15, 2002. Page 4 of 26
SCHEDULE 13D CUSIP No. 759351109 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) General American Life Insurance Company 43-0285930 - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable - ------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Missouri - ------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY None* OWNED BY ---------------------------------------------------------- EACH 8 SHARED VOTING POWER REPORTING PERSON 24,131,250* WITH ---------------------------------------------------------- 9 SOLE DISPOSITIVE POWER None* ---------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 24,131,250* - ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 24,131,250* - ------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] - ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 48.8%* - ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IC - ------------------------------------------------------------------------------- * See Item 5 below. Unless otherwise indicated, all information relating to beneficial ownership of the Shares by the Reporting Persons is as of February 15, 2002. Page 5 of 26
SCHEDULE 13D CUSIP No. 759351109 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Equity Intermediary Company 43-1727895 - ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] - ------------------------------------------------------------------------------- 3 SEC USE ONLY - ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable - ------------------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Missouri - ------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER SHARES BENEFICIALLY None* OWNED BY ---------------------------------------------------------- EACH 8 SHARED VOTING POWER REPORTING PERSON 24,131,250* WITH ---------------------------------------------------------- 9 SOLE DISPOSITIVE POWER None* ---------------------------------------------------------- 10 SHARED DISPOSITIVE POWER 24,131,250* - ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 24,131,250* - ------------------------------------------------------------------------------- 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] - ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 48.8%* - ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON HC, CO - ------------------------------------------------------------------------------- * See Item 5 below. Unless otherwise indicated, all information relating to beneficial ownership of the Shares by the Reporting Persons is as of February 15, 2002. Page 6 of 26
SCHEDULE 13D CUSIP No. 759351109 This Statement relates to the common stock, par value $.01 per share (the "Shares"), of Reinsurance Group of America, Incorporated, a Missouri corporation ("RGA"). This Statement amends the Schedule 13D Statement of MetLife, Inc. in respect of RGA by amending and restating Items 2,5 and 7 in their entirety, as follows: Item 2. Identity and Background. (a) through (c) and (f). This Statement is filed on behalf of (i) MetLife, Inc. ("MLINC"), (ii) Metropolitan Life Insurance Company ("MetLife"), a wholly owned subsidiary of MLINC, (iii) GenAmerica Financial Corporation, a wholly owned subsidiary of MetLife ("GenAmerica"), (iv) General American Life Insurance Company, a wholly owned subsidiary of GenAmerica ("GenAm Life"), and (v) Equity Intermediary Company, a wholly owned subsidiary of GenAm Life ("EIM") (MLINC, MetLife, GenAmerica, GenAm Life and EIM are referred to herein collectively as the "Filing Parties"). MLINC, a Delaware corporation with its principal office and business at One Madison Avenue, New York, NY, 10010-3690, is not controlled by any person or persons and is a holding company which owns all of the issued and outstanding shares of common stock of MetLife. MetLife, a New York life insurance company, has its principal office and business at One Madison Avenue, New York, New York 10010-3690. GenAmerica and EIM are holding companies and GenAm Life is an insurance company. GenAmerica, GenAm Life and EIM are each Missouri corporations with the address of their principal offices and businesses at 700 Market Street, St. Louis, Missouri 63101. Set forth on Exhibit A to this Statement, and incorporated herein by reference, is the name, residence or business address, present principal occupation or employment (and the name, principal business and address of any corporation or other organization in which such employment is conducted) and citizenship of each director and executive officer of the Filing Parties. (d) During the last five years, none of the Filing Parties nor, to the best knowledge of the Filing Parties, any of their respective executive officers or directors has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) During the last five years, none of the Filing Parties nor, to the best knowledge of the Filing Parties, any of their respective executive officers or directors has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. Item 5. Interest in Securities of the Issuer. (a) and (b). As of February 15, 2002, MLINC and MetLife beneficially owned 29,138,739 Shares, or approximately 58.9 percent of the outstanding Shares. Of such Shares, MLINC has sole voting and dispositive power with respect to 222,800 Shares, MLINC and MetLife share voting and dispositive power with each other with respect to 4,784,689 Shares and share voting and dispositive power with GenAmerica, GenAm Life and EIM with respect to 24,131,250 Shares. As of February 15, 2002, GenAmerica, GenAm Life and EIM beneficially owned 24,131,250 Shares, or approximately 48.8 percent of the outstanding Shares. With respect to such Shares, GenAmerica, GenAm Life and EIM share voting and dispositive power with MLINC, MetLife and each other. See also Item 2 above. The information in the following paragraphs is to the best knowledge of the Filing Parties. Page 7 of 26
SCHEDULE 13D CUSIP No. 759351109 As of February 2, 2002, William E. Cornelius, a director of GenAmerica and GenAm Life, beneficially owned 1,113 Shares and had sole voting and dispositive power with respect to such Shares. As of February 19, 2002, Arnold W. Donald, a director of GenAmerica and GenAm Life, may be deemed to be the beneficial owner of 105 Shares held by Hazel Donald, as trustee of a trust. Mr. Donald did not have voting or dispositive power with respect to such Shares. As of February 1, 2002, Richard D. Evans, Senior Vice President - Sales, National Accounts and Special Programs of GenAm Life, beneficially owned 100 Shares and had sole voting and dispositive power with respect to such Shares. As of February 14, 2002, James W. Koeger, Vice President of MetLife and a director of EIM, beneficially owned 700 Shares and had sole voting and dispositive power with respect to such Shares. As of February 5, 2002, Richard A. Liddy, Chairman of GenAmerica and GenAm Life, may be deemed to have been the beneficial owner of 132,200 Shares, (i) 112,500 Shares which were owned directly by Mr. Liddy, and (ii) 19,700 Shares which were owned by Joanne S. Liddy, his spouse. Mr. Liddy had sole voting and dispositive power with respect to the shares owned directly by him, and shared voting and dispositive power with respect to such Shares owned by his spouse. Mr. Liddy disclaimed beneficial ownership of the aforementioned Shares owned by his spouse. As of February 4, 2002, Matthew P. McCauley, a director of EIM and Vice-President, General Counsel and Secretary of GenAmerica and GenAm Life, beneficially owned 1,000 Shares which were jointly owned with Brigid K. McCauley, and shared voting and dispositive power with respect to such Shares with her. As of February 1, 2002, Stewart G. Nagler, Vice Chairman of the Board and Chief Financial Officer of MLINC and MetLife, a director of GenAmerica and GenAm Life and Chairman of the Board of RGA, beneficially owned 1,000 Shares and had sole voting and dispositive power with respect to such Shares. As of February 4, 2002, John E. Petersen, Senior Vice President of GenAm Life, beneficially owned 150 Shares and had sole voting and dispositive power with respect to such Shares. As of February 14, 2002, Craig D. Schnuck, a director of GenAmerica and GenAm Life, beneficially owned 2,000 Shares and had sole voting and dispositive power with respect to such Shares. As of February 6, 2002, William P. Stiritz, a director of GenAmerica and GenAm Life, beneficially owned 9,933 Shares and had sole voting and dispositive power with respect to such Shares. As of February 4, 2002, Andrew C. Taylor, a director of GenAmerica and GenAm Life, beneficially owned 26,000 Shares and shared voting and dispositive power with respect to such Shares with Barbara B. Taylor. As of February 5, 2002, Robert L. Virgil, a director of GenAmerica and GenAm Life, beneficially owned 225 Shares which were owned by Geraldine J. Virgil, his spouse, and shared voting and dispositive power with respect to such Shares with her. Page 8 of 26
SCHEDULE 13D CUSIP No. 759351109 As of February 2, 2002, Virginia V. Weldon, M.D. a director of GenAmerica and GenAm Life, beneficially owned 450 Shares as trustee of a trust, and had sole voting and dispositive power with respect to such Shares. As of February 4, 2002, Bernard H. Wolzenski, Executive Vice-President - - Individual, of GenAmerica and GenAm Life, may be deemed to be the beneficial owner of 2,725 Shares held by Jeanne A. Wolzenski, as trustee of a trust. Mr. Wolzenski did not have voting or dispositive power with respect to such Shares. As of February 6, 2002, A. Greig Woodring, Executive Vice-President - Reinsurance of GenAmerica and GenAm Life and President and Chief Executive Officer of RGA, may be deemed to have been the beneficial owner of 323,557 Shares and had sole voting and dispositive power with respect to such Shares. Some of the Shares described in the above paragraphs may be in the form of stock options exercisable within 60 days or restricted stock. None of the Share ownership described in the above paragraphs represents beneficial ownership by any individual of more than 1% of the outstanding Shares. The percentage amounts set forth in this Item 5 are based upon the number of Shares issued and outstanding as of October 31, 2001, as described in RGA's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2001. (c) In the 60 days prior to the date of filing of this Statement, none of the Filing Parties nor, to the best knowledge of the Filing Parties, any of their respective directors and executive officers has effected any transactions in the Shares, except as disclosed in this Statement, and except the following: Susan Stiritz sold 17,500 Shares on January 9, 2002 at $32.00 per Share. Stewart G. Nagler purchased 1,000 Shares on February 1, 2002 at $29.00 per Share. Between January 30, 2002 and February 15, 2002, MLINC purchased a total of 222,800 Shares. Details regarding these purchases are set forth in Exhibit C hereto. (d) No other person is known by the Filing Parties to have the right to receive or the power to direct the receipt of dividends from, and the proceeds from the sale of, the Shares. (e) Not applicable. Item 7. Materials to be Filed as Exhibits. Exhibit A -- Information relating to the Executive Officers and Directors of the Filing Parties Exhibit B -- Agreement Required for Joint Filing under Rule 13d-1(k)(1) Exhibit C -- Purchases of Shares by MetLife, Inc. Page 9 of 26
SCHEDULE 13D CUSIP No. 759351109 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 20, 2002 METLIFE, INC. By: /s/ Gwenn L. Carr ----------------- Name: Gwenn L. Carr Title: Vice-President and Secretary METROPOLITAN LIFE INSURANCE COMPANY By: /s/ Gwenn L. Carr ----------------- Name: Gwenn L. Carr Title: Vice-President and Secretary GENAMERICA FINANCIAL CORPORATION By: /s/ Matthew P. McCauley ----------------------- Name: Matthew P. McCauley Title: Vice-President, General Counsel and Secretary GENERAL AMERICAN LIFE INSURANCE COMPANY By: /s/ Matthew P. McCauley ------------------------ Name: Matthew P. McCauley Title: Vice-President, General Counsel and Secretary EQUITY INTERMEDIARY COMPANY By: /s/ Matthew P. McCauley ------------------------ Name: Matthew P. McCauley Title: Director, Vice-President, General Counsel and Secretary Page 10 of 26
SCHEDULE 13D CUSIP No. 759351109 EXHIBIT A DIRECTORS AND EXECUTIVE OFFICERS OF THE FILING PARTIES Set forth below is the name and present principal occupation or employment of each director and executive officer of MLINC and MetLife. MLINC is a holding company and MetLife is an insurance company. The principal business address of MLINC and MetLife is One Madison Avenue, New York, NY 10010-3690. Each person listed below is a citizen of the United States. DIRECTORS Name And Business Address Principal Occupation or Employment - ------------------------- ---------------------------------- Curtis H. Barnette Of Counsel, Skadden, Arps, Slate, Skadden, Arps, Slate, Meagher & Flom LLP (law firm) Meagher & Flom LLP 1440 New York Avenue, N.W. Washington, DC 20005-2111 Robert H. Benmosche Chairman of the Board, President and Chief Executive Officer, MLINC and MetLife Gerald Clark Vice-Chairman of the Board and Chief Investment Officer, MLINC and MetLife Joan Ganz Cooney* Chairman, Executive Committee Children's Television Workshop Children's Television Workshop One Lincoln Plaza (broadcasting) New York, New York 10023 John C. Danforth Partner, Bryan Cave LLP (law firm) Bryan Cave LLP 211 N. Broadway, Suite 3600 St. Louis, MO 63102-2750 Burton A. Dole, Jr. Retired Chairman, President and P.O. Box 208 Chief Executive Officer, Puritan Pauma Valley, Bennett, Incorporated (medical device California 92061 manufacturing) James R. Houghton Non-Executive Chairman of the Board, Corning Incorporated Corning Incorporated (telecommunications 80 East Market Street technology) 2nd Floor, Corning, New York 14830 Harry P. Kamen Retired Chairman of the Board and Metropolitan Life Insurance Co. Chief Executive Officer, MetLife 200 Park Avenue, Suite 5700 New York, New York 10166 Page 11 of 26
SCHEDULE 13D CUSIP No. 759351109 Helene L. Kaplan Of Counsel, Skadden, Arps, Slate, Skadden, Arps, Slate, Meagher and Flom LLP (law firm) Meagher & Flom LLP Four Times Square New York, New York 10036 Catherine R. Kinney Co-Chief Operating Officer, President New York Stock Exchange, Inc. and Executive Vice Chairman, New York 20 Broad Street Stock Exchange, Inc. New York, New York 10005 Charles M. Leighton Retired Chairman and Chief Executive P. O. Box 247 Officer, CML Group, Inc. (exercise Bolton, MA 01740 and leisure products) Allen E. Murray* Retired Chairman of the Board and Mobil Corporation Chief Executive Officer, Mobil 375 Park Avenue, Suite 2901 Corporation (petroleum refining) New York, New York 10152 Stewart G. Nagler Vice-Chairman of the Board and Chief Financial Officer, MLINC and MetLife; Chairman of the Board, RGA John J. Phelan, Jr. Senior Advisor, Boston Consulting Group P.O. Box 312 Mill Neck, New York 11765 Hugh B. Price President and Chief Executive National Urban League, Inc. Officer, National Urban League, Inc. 500 East 62nd Street New York, New York 10005 William G. Steere, Jr. Retired Chairman of the Board and Chief Pfizer Inc. Executive Officer, Pfizer Inc. 235 East 42nd Street New York, New York 10017 * Joan Ganz Cooney and Allen Murray will retire from the Boards of MLINC and MetLife effective March 31, 2002. Executive Officers (Who are not Directors) Name Principal Occupation or Employment - ---- ---------------------------------- Gary A. Beller Senior Executive Vice-President and General Counsel, MLINC and MetLife James M. Benson President, Individual Business, MLINC and MetLife; Chairman, Chief Executive Officer and President, New England Life Insurance Company C. Robert Henrikson President, Institutional Business, MLINC and MetLife Page 12 of 26
SCHEDULE 13D CUSIP No. 759351109 Catherine A. Rein Senior Executive Vice-President, MLINC and MetLife; President and Chief Executive Officer, Metropolitan Property and Casualty Insurance Company William J. Toppeta President, International, MLINC and MetLife Lisa M. Weber Senior Executive Vice-President and Chief Administrative Officer, MLINC and MetLife Set forth below is the name and present principal occupation or employment of each director and executive officer of GenAmerica and GenAm Life. GenAmerica is a holding company and GenAm Life is an insurance company. The principal business address of each of GenAmerica and GenAm Life is 700 Market Street, St. Louis, Missouri 63101. Each person listed below is a citizen of the United States. DIRECTORS Name And Business Address Principal Occupation or Employment - ------------------------- ---------------------------------- James M. Benson President, Individual Business, MLINC and Metropolitan Life Insurance Co. MetLife; Chairman, Chief Executive Officer One Madison Avenue and President, New England Life New York, New York 10010-3690 Insurance Company William E. Cornelius Retired Chairman and Chief Executive Officer #2 Dunlora Lane Union Electric Company (now Ameren St. Louis, Missouri 63131 Corporation) (electric utility) John C. Danforth Partner, Bryan Cave LLP (law firm) Bryan Cave LLP One Metropolitan Square, Suite 3600 St. Louis, Missouri 63102 Arnold W. Donald Chairman and Chief Executive Officer, Merisant Company Merisant Company 1 N. Brentwood Blvd. Suite 510 St. Louis, MO 63105 Kevin C. Eichner President and Chief Executive Officer, GenAmerica and GenAm Life Jerald L. Kent President and Chief Executive Officer, 12412 Powerscourt Dr. Cequel III, LLC Suite 100 St. Louis, MO 63131 Richard A. Liddy Chairman, Retired President and Chief Executive Officer, GenAmerica and GenAm Life Page 13 of 26
SCHEDULE 13D CUSIP No. 759351109 Stewart G. Nagler Vice-Chairman of the Board and Chief Metropolitan Life Insurance Co. Financial Officer, MLINC and MetLife; One Madison Avenue Chairman of the Board, RGA New York, New York 10010-3690 Craig D. Schnuck Chairman and Chief Executive Officer, Schnuck Markets, Inc. Schnuck Markets, Inc. (retail grocery 11420 Lackland Road stores) St. Louis, Missouri 63146 William P. Stiritz Chairman, Energizer Holding Company and Agribrands International, Inc. Ralcorp Holdings Inc. 1401 South Brentwood Blvd. Suite 650 St. Louis, Missouri 63144 Andrew C. Taylor Chairman and Chief Executive Officer, Enterprise Rent-A-Car Company Enterprise Rent-A-Car Company (automobile 600 Corporate Park Drive rental and leasing) St. Louis, Missouri 63105 Robert L. Virgil Management Consultant and Subordinated Edward Jones & Co. Limited Partner, Edward Jones & Co. 12555 Manchester Road (securities firm) St. Louis, Missouri 63131 Lisa M. Weber Senior Executive Vice-President and Chief Metropolitan Life Insurance Co. Administrative Officer, MLINC and MetLife One Madison Avenue New York, New York 10010-3690 Virginia V. Weldon Retired Senior Vice-President for Public 242 Carlyle Lake Drive Policy, Monsanto Company (life sciences) St. Louis, Missouri 63141 Executive Officers of GenAmerica and/or GenAm Life (Who Are Not Directors) Name Principal Occupation or Employment - ---- ---------------------------------- Richard D. Evans Senior Vice-President - Sales, National Accounts and Special Programs, GenAm Life Timothy J. Klopfenstein Vice President and Chief Financial Officer, Individual Product Division, GenAm Life; President and Treasurer, EIM Matthew P. McCauley Vice-President, General Counsel and Secretary, GenAmerica and GenAm Life Daniel J. McDonald Senior Vice-President, GenAm Life Richard J. Miller Executive Vice-President and Chief Marketing Officer, GenAm Life Jerome M. Mueller Senior Vice-President - National Marketing, GenAm Life Page 14 of 26
SCHEDULE 13D CUSIP No. 759351109 John E. Petersen Senior Vice-President, GenAm Life William S. Slater Senior Vice-President, GenAm Life Bernard H. Wolzenski Executive Vice-President - Individual, GenAmerica and GenAm Life A. Greig Woodring Executive Vice-President - Reinsurance, RGA GenAmerica and GenAm Life; President and 1370 Timberlake Parkway Chief Executive Officer, RGA Chesterfield, MO 63017 Set forth below is the name and present principal occupation or employment of each director and executive officer of EIM. EIM is a holding company. The principal business address of EIM is 700 Market Street, St. Louis, Missouri 63101. Each person listed below is a citizen of the United States. DIRECTORS Name And Business Address Principal Occupation or Employment - ------------------------- ---------------------------------- Timothy J. Klopfenstein Vice President and Chief Financial Officer, Individual Product Division, GenAm Life; President and Treasurer, EIM James W. Koeger Vice President, MetLife; Assistant Treasurer, GenAmerica, GenAm Life and EIM Matthew P. McCauley Vice-President, General Counsel and Secretary, GenAmerica, GenAm Life and EIM Page 15 of 26
SCHEDULE 13D CUSIP No. 759351109 Exhibit B Joint Filing Agreement In accordance with Rule 13d-1(k)(1) of Regulation 13D-G of the Securities Exchange Act of 1934, the persons or entities below agree to the joint filing on behalf of each of them of the Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Stock of Reinsurance Group of America, Incorporated, and agree that such statement is, and any amendments thereto filed by any of them will be, filed on behalf of each of them, and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof the undersigned hereby execute this Agreement this 20th day of February, 2002. METLIFE, INC. By: /s/ Gwenn L. Carr ----------------- Name: Gwenn L. Carr Title: Vice-President and Secretary METROPOLITAN LIFE INSURANCE COMPANY By: /s/ Gwenn L. Carr ----------------- Name: Gwenn L. Carr Title: Vice-President and Secretary GENAMERICA FINANCIAL CORPORATION By: /s/ Matthew P. McCauley ----------------------- Name: Matthew P. McCauley Title: Vice-President, General Counsel and Secretary GENERAL AMERICAN LIFE INSURANCE COMPANY By: /s/ Matthew P. McCauley ----------------------- Name: Matthew P. McCauley Title: Vice-President, General Counsel and Secretary EQUITY INTERMEDIARY COMPANY By: /s/ Matthew P. McCauley ----------------------- Name: Matthew P. McCauley Title: Director, Vice-President, General Counsel and Secretary Page 16 of 26
SCHEDULE 13D CUSIP No. 759351109 Exhibit C Purchases of Shares by MetLife, Inc. January 30, 2002 SHARES TRADE LOT PURCHASED PRICE - --------- --------- ------- 1 600 27.64 2 700 27.66 3 1800 27.7 4 100 27.72 5 400 27.73 6 1800 27.75 7 4000 27.78 8 1400 27.79 9 4000 27.8 10 800 27.82 11 13200 27.85 12 1700 27.88 13 4500 27.89 14 9700 27.9 15 6200 27.91 16 400 27.92 17 100 27.94 18 1100 27.95 19 900 27.96 20 4700 27.98 21 5300 27.99 22 12600 28.00 76,000 27.8924 Page 17 of 26
SCHEDULE 13D CUSIP No. 759351109 January 31, 2002 SHARES TRADE LOT PURCHASED PRICE - --------- --------- ------- 1 1250 27.99 2 750 28 3 250 28.1 4 1350 28.25 5 50 28.26 6 1850 28.3 7 1000 28.33 8 200 28.34 9 200 28.35 10 150 28.39 11 100 28.4 12 250 28.41 13 500 28.45 14 150 28.52 15 850 28.54 16 1100 28.55 17 200 28.62 18 550 28.64 19 500 28.7 20 100 28.71 21 150 28.72 11,500 28.3443 February 1, 2002 SHARES TRADE LOT PURCHASED PRICE - --------- --------- ------- 1 150 28.63 2 400 28.65 3 3850 28.7 4 300 28.71 5 5400 28.75 6 300 28.76 7 150 28.77 8 3450 28.79 9 1000 28.8 10 1350 28.92 11 450 28.93 12 3200 29 20,000 28.8021 Page 18 of 26
SCHEDULE 13D CUSIP No. 759351109 February 4, 2002 SHARES TRADE LOT PURCHASED PRICE - --------- --------- ------- 1 50 28.34 2 300 28.35 3 1650 28.39 4 950 28.4 5 650 28.44 6 100 28.45 7 550 28.46 8 100 28.47 9 350 28.5 10 700 28.55 11 1400 28.56 12 1100 28.57 13 4250 28.59 14 350 28.6 15 1450 28.9 16 50 28.95 14,000 28.5584 Page 19 of 26
SCHEDULE 13D CUSIP No. 759351109 February 5, 2002 SHARES TRADE LOT PURCHASED PRICE - --------- --------- ------- 1 250 27.85 2 250 27.95 3 100 28 4 500 28.03 5 250 28.05 6 150 28.06 7 50 28.09 8 450 28.1 9 1,450 28.11 10 450 28.12 11 100 28.13 12 800 28.15 13 150 28.19 14 1,050 28.21 15 350 28.22 16 450 28.25 17 100 28.28 18 250 28.3 19 200 28.31 20 100 28.33 21 650 28.35 22 50 28.39 23 100 28.4 24 400 28.47 25 900 28.55 9,550 28.2083 Page 20 of 26
SCHEDULE 13D CUSIP No. 759351109 February 6, 2002 SHARES TRADE LOT PURCHASED PRICE - --------- --------- ------- 1 50 28.15 2 450 28.16 3 150 28.17 4 300 28.22 5 700 28.23 6 50 28.25 7 100 28.29 8 900 28.3 9 1300 28.31 10 2500 28.35 11 250 28.36 12 350 28.37 13 250 28.38 14 1200 28.42 15 850 28.43 16 1600 28.44 11,000 28.3463 February 7, 2002 SHARES TRADE LOT PURCHASED PRICE - --------- --------- ------- 1 600 28.05 2 1450 28.1 3 700 28.14 4 50 28.19 5 150 28.2 6 1100 28.21 7 50 28.22 8 50 28.23 9 250 28.24 10 100 28.26 11 750 28.3 12 500 28.39 13 750 28.4 6,500 28.2111 Page 21 of 26
SCHEDULE 13D CUSIP No. 759351109 February 8, 2002 SHARES TRADE LOT PURCHASED PRICE - --------- --------- ------- 1 200 28.45 2 50 28.50 3 50 28.55 4 50 28.60 5 350 28.70 6 100 28.78 7 50 28.79 8 50 28.80 9 50 28.81 10 4,900 28.82 11 750 28.83 12 200 28.84 13 100 28.86 14 100 28.88 15 950 28.89 16 500 28.90 17 400 28.92 18 450 28.93 19 500 28.94 20 150 28.95 21 150 28.96 22 1,100 28.97 23 3,700 28.99 24 1,850 29.00 16,750 28.8965 Page 22 of 26
SCHEDULE 13D CUSIP No. 759351109 February 11, 2002 SHARES TRADE LOT PURCHASED PRICE - --------- --------- ------- 1 150 29.03 2 250 29.10 3 200 29.15 4 650 29.18 5 350 29.20 6 950 29.25 7 250 29.27 8 550 29.28 9 150 29.29 10 100 29.30 11 200 29.34 12 50 29.35 13 200 29.36 14 150 29.37 15 150 29.38 16 1,700 29.39 17 250 29.40 18 200 29.43 19 250 29.45 20 50 29.50 21 300 29.51 22 350 29.52 23 150 29.54 24 550 29.55 25 50 29.60 26 50 29.64 27 1,250 29.65 28 50 29.67 29 50 29.68 30 1,400 29.70 11,000 29.4251 Page 23 of 26
SCHEDULE 13D CUSIP No. 759351109 February 12, 2002 SHARES TRADE LOT PURCHASED PRICE - --------- --------- ------- 1 900 29.20 2 600 29.22 3 1,200 29.30 4 700 29.31 5 250 29.32 6 500 29.33 7 350 29.34 8 50 29.37 9 300 29.38 10 2,000 29.39 11 650 29.40 12 800 29.45 13 300 29.46 14 100 29.48 15 300 29.52 16 50 29.54 17 100 29.55 18 50 29.56 19 300 29.57 20 150 29.58 21 200 29.59 22 950 29.60 23 1,700 29.61 12,500 29.4176 Page 24 of 26
SCHEDULE 13D CUSIP No. 759351109 February 13, 2002 SHARES TRADE LOT PURCHASED PRICE - --------- --------- ------- 1 100 29.07 2 50 29.09 3 250 29.15 4 250 29.20 5 100 29.21 6 850 29.27 7 150 29.28 8 50 29.30 9 1,000 29.40 10 250 29.41 11 550 29.43 12 400 29.47 13 100 29.49 14 700 29.50 15 150 29.51 16 850 29.55 17 650 29.58 18 750 29.59 19 2,300 29.60 20 250 29.75 21 150 29.81 22 300 29.83 23 450 29.84 24 850 29.85 11,500 29.5334 Page 25 of 26
SCHEDULE 13D CUSIP No. 759351109 February 14, 2002 SHARES TRADE LOT PURCHASED PRICE - --------- --------- ------- 1 500 29.50 2 250 29.55 3 2,000 29.59 4 1,250 29.60 5 450 29.69 6 1,550 29.70 7 100 29.77 8 1,100 29.80 9 750 29.82 10 500 29.85 11 100 29.86 12 200 29.87 13 150 29.89 14 100 29.95 15 3,000 30.00 12,000 29.7665 February 15, 2002 SHARES TRADE LOT PURCHASED PRICE - --------- --------- ------- 1 1,300 29.54 2 200 29.55 3 100 29.59 4 900 29.62 5 500 29.65 6 600 29.66 7 350 29.67 8 50 29.70 9 1,750 29.74 10 50 29.75 11 200 29.78 12 1,500 29.85 13 500 29.86 14 1,000 29.87 15 100 29.88 16 50 29.89 17 1,350 29.90 10,500 29.7458 Page 26 of 26